Showing results (361-370 of 1,003) with videos related to

Sort By:
Pageof 101
Cardiovascular Therapeutics|September 3, 2011
Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosisPandula Athauda-Arachchi, Chim Lang
Cardiovascular Therapeutics|September 3, 2011
Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humansMarco Bucci, Ronald Borra, Kjell Någren, et al.
Cardiovascular Therapeutics|September 3, 2011
Matricellular proteins: new molecular targets to prevent heart failureHiroshi Okamoto, Kyoko Imanaka-Yoshida
Cardiovascular Therapeutics|September 3, 2011
Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarctionJing-Lin Zhao, Chao-Mei Fan, Yue-Jin Yang, et al.
Cardiovascular Therapeutics|September 3, 2011
Is angiotensin-converting enzyme inhibitor a contraindication for contrast-induced nephropathy prophylaxis? A review about its paradoxXiming Li, Tingting Li, Hongliang Cong
Cardiovascular Therapeutics|November 13, 2010
Thrombolytics and myocardial infarctionVijayalakshmi Kunadian, C Michael Gibson
Cardiovascular Therapeutics|October 5, 2011
Do statins have a role in reduction/prevention of post-PCI restenosis?Kailash Prasad
Cardiovascular Therapeutics|January 4, 2012
N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin CEmin Alioglu, Serkan Saygi, Ugur Turk, et al.
Cardiovascular Therapeutics|November 16, 2010
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and managementJean-Luc Reny, Robert F Bonvini, John M Bonvini, et al.
Cardiovascular Therapeutics|April 25, 2014
Pentoxifylline in heart failure: a meta-analysis of clinical trialsSébastien Champion, Nathanaël Lapidus, Godefroy Cherié, et al.
Pageof 101